TME Pharma NV (FRA:0N6A) Shares Buyback Ratio % : -158.11 (As of May. 11, 2025)

View and export this data going back to 2018. Start your Free Trial

What is TME Pharma NV Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. TME Pharma NV's current shares buyback ratio was -158.11%.

TME Pharma NV Shares Buyback Ratio % Historical Data

The historical data trend for TME Pharma NV's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TME Pharma NV Shares Buyback Ratio % Chart

TME Pharma NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-261.14

-58.11

-131.58

-808.27

-108.16

TME Pharma NV Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-131.58	-207.37	-195.50	-143.68	-5.92

TME Pharma NV Shares Buyback Ratio % Calculation

TME Pharma NV's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(23.179	-	48.250)	/	23.179
	=	-108.16%

TME Pharma NV's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	(56.482	-	59.827)	/	56.482
	=	-5.92%

TME Pharma NV Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of TME Pharma NV's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

TME Pharma NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TME Pharma NV (FRA:0N6A) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

ALTME:France

Address

Max-Dohrn-Street 8-10, Berlin, DEU, 10589

Website

https://www.tmepharma.com

TME Pharma NV is a clinical-stage biopharmaceutical company engaged in improving cancer treatment by targeting the tumor microenvironment and focusing on the improvement in the effectiveness of cancer therapies. Its product is NOX-A12 which is being developed in solid tumors. In the Phase 1/2 trial in chemotherapy-resistant 1st line glioblastoma (brain cancer) patients, NOX-12 + radiotherapy + anti-VEGF has shown a statistically survival benefit over both standard of care reference cohort (p=0.003, HR: 0.30) and as well as vs. patients receiving NOX-A12 and radiotherapy alone (p=0.021, HR: 0.34).

TME Pharma NV Headlines

No Headlines